机译:曲妥珠单抗联合卡培他滨成功治疗乳腺癌的软脑膜转移:1例
Department of Breast Oncology Saitama Medical University International Medical Center 1397-1 Yamane Hidaka Saitama 350-1298 Japan;
Department of Breast Oncology Saitama Medical University International Medical Center 1397-1 Yamane Hidaka Saitama 350-1298 Japan;
Department of Breast Oncology Saitama Medical University International Medical Center 1397-1 Yamane Hidaka Saitama 350-1298 Japan;
Department of Breast Oncology Saitama Medical University International Medical Center 1397-1 Yamane Hidaka Saitama 350-1298 Japan;
Department of Breast Oncology Saitama Medical University International Medical Center 1397-1 Yamane Hidaka Saitama 350-1298 Japan;
Department of Breast Oncology Saitama Medical University International Medical Center 1397-1 Yamane Hidaka Saitama 350-1298 Japan;
Department of Breast Oncology Saitama Medical University International Medical Center 1397-1 Yamane Hidaka Saitama 350-1298 Japan;
Department of Breast Oncology Saitama Medical University International Medical Center 1397-1 Yamane Hidaka Saitama 350-1298 Japan;
Department of Surgery National Hospital Organization Shikoku Cancer Center 160 Kou Minamiumemoto Matsuyama Ehime 791-0280 Japan;
Department of Breast Oncology Saitama Medical University International Medical Center 1397-1 Yamane Hidaka Saitama 350-1298 Japan;
Breast cancer; Leptomeningeal metastasis; Trastuzumab; Capecitabine;
机译:TBCRC049:II期非随机性研究,以评估Tucatinib和Trastuzumab和Capecitabine的组合的安全性和功效,用于治疗Her2阳性乳腺癌TBCRC049中的百分声膜转移:II期非随机性研究,以评估安全性和疗效 Tucatinib和Trastuzumab和Capecitabine的组合治疗HER2阳性乳腺癌中的百分症转移
机译:卡培他滨联合长春瑞滨和曲妥珠单抗用于HER2阳性转移性乳腺癌的一线或二线治疗的II期介入研究(N0337)
机译:Erlotinib在治疗失败后来自Her2阳性乳腺癌的进步性脑和瘦性的脑膜转移:文学经验和审查
机译:皮肤癌转移的最小毒性方法:卡培他滨增强的光动力疗法
机译:荧光原位杂交(FISH)检测HER-2 / neu对曲妥珠单抗治疗转移性乳腺癌的影响。
机译:Capecitabine的II期介入研究(N0337)与血列林和曲妥珠单抗组合的HER2阳性转移性乳腺癌的第一或二线治疗:北中央癌症治疗组试验
机译:巴西卡培他汀对卡西他滨对卡培他滨单独治疗的拉帕替尼和卡培他滨对卡培他滨单独治疗的曲妥珠单抗的PCN24成本效益分析